Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory miRNAs and lncRNAs in Skin Cancer: A Narrative Review. | Life (Basel) | 2023 | 37629553 | PubTator, text mining | PubMed |
| Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway. | Biomedicines | 2023 | 37626810 | PubTator, text mining | PubMed |
| The Spectrum of Molecular Pathways in Gliomas-An Up-to-Date Review. | Biomedicines | 2023 | 37626776 | PubTator, text mining | PubMed |
| SPOP targets the immune transcription factor IRF1 for proteasomal degradation. | Elife | 2023 | 37622993 | PubTator, text mining | PubMed |
| Retracted: Role of MiR-27a-3p in Intervertebral Disc Degeneration through Targeting RASSF5 via MST1/LATS1 and RAS/RAC1 Signaling Pathway. | J Healthc Eng | 2023 | 37621640 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37614318 | PubTator, text mining | PubMed |
| Protease-independent control of parthanatos by HtrA2/Omi. | Cell Mol Life Sci | 2023 | 37594630 | PubTator, text mining | PubMed |
| The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway. | iScience | 2023 | 37593458 | PubTator, text mining | PubMed |
| AXL activates YAP through the EGFR-LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma. | Oncogene | 2023 | 37591955 | PubTator, text mining | PubMed |
| CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties. | Signal Transduct Target Ther | 2023 | 37582812 | PubTator, text mining | PubMed |
| m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. | Mol Cancer | 2023 | 37582735 | PubTator, text mining | PubMed |
| New insights into the important roles of phase seperation in the targeted therapy of lung cancer. | Cell Biosci | 2023 | 37580790 | PubTator, text mining | PubMed |
| Emerging role of Hippo pathway in the regulation of hematopoiesis. | BMB Rep | 2023 | 37574808 | PubTator, text mining | PubMed |
| YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer. | Int J Mol Sci | 2023 | 37569866 | PubTator, text mining | PubMed |
| Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer. | Cancers (Basel) | 2023 | 37568716 | PubTator, text mining | PubMed |
| miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets. | J Cell Mol Med | 2023 | 37555915 | PubTator, text mining | PubMed |
| Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance. | J Exp Clin Cancer Res | 2023 | 37553567 | PubTator, text mining | PubMed |
| DNAJB4 suppresses breast cancer progression and promotes tumor immunity by regulating the Hippo signaling pathway. | Discov Oncol | 2023 | 37548821 | PubTator, text mining | PubMed |
| Synaptopodin-2: a potential tumor suppressor. | Cancer Cell Int | 2023 | 37544991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=17